Bromochlorosalicylanilide
Chemical compound
- D01AE01 (WHO)
- 5-Bromo-N-(4-chlorophenyl)-2-hydroxybenzamide
- 3679-64-9
- 77254
- 69679
- 6GK715PWMQ
- ChEMBL153192
- DTXSID80190256
- Interactive image
- Brc2cc(C(=O)Nc1ccc(Cl)cc1)c(O)cc2
Bromochlorosalicylanilide is an antifungal.[1] It may cause allergic contact dermatitis in some individuals.[2]
References
- ^ Weuffen W, Wagner G, Singer D, Petermann M (1966). "2-Hydroxythiobenzamides and 2-hydroxythiobenzanilides. III. Fungicidal properties". Pharmazie. 21 (10): 613–19.
- ^ Buckley DB (May 1986). "Allergic contact dermatitis to bromsalicylchloranilide". Contact Dermatitis. 14 (5): 319. doi:10.1111/j.1600-0536.1986.tb05290.x. PMID 3743047. S2CID 71597136.
- v
- t
- e
Antifungals (D01 and J02)
membrane
Ergosterol inhibitors |
| ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β-glucan synthase inhibitors |
Pyrimidine analogues/ thymidylate synthase inhibitors |
|
---|---|
Mitotic inhibitors |
|
Aminoacyl tRNA synthetase inhibitors |
|
- bromochlorosalicylanilide
- chlorophetanol
- chlorphenesin
- ciclopirox
- crystal violet
- dimazole
- ethylparaben
- haloprogin‡
- polynoxylin
- potassium iodide#
- salicylic acid
- selenium disulfide#
- sodium thiosulfate#
- sulbentine
- taurolidine
- ticlatone
- tolciclate
- tolnaftate
- tribromometacresol
- undecylenic acid
- Whitfield's ointment#
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e